P1151: METABOLIC TUMOR VOLUME IMPROVES OUTCOME PREDICTION IN UNTREATED MANTLE CELL LYMPHOMA

P1151: METABOLIC TUMOR VOLUME IMPROVES OUTCOME PREDICTION IN UNTREATED MANTLE CELL LYMPHOMA

Bibliographic Details
Main Authors:	V. K. Vergote, G. Verhoef, A. Janssens, F. S. Woei-a-jin, A. Laenen, T. Tousseyn, D. Dierickx, C. M. Deroose
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000847472.18815.c3

Similar Items

1151 Antibody-drug conjugates targeting CLDN18.2 for the treatment of solid tumors
by: Jun Li, et al.
Published: (2023-11-01)

THE SIGNIFICANCE OF DIRECTIVE 2019/1151 IN THE DIGITALIZATION OF EUROPEAN UNION COMPANY LAW
by: Nina Maksimović Sekulić
Published: (2023-10-01)

Cytogenetics of mantle cell lymphoma
by: T N Obukhova, et al.
Published: (2004-07-01)

Rituximab and Bendamustine (BR) Compared with Rituximab, Bendamustine, and Cytarabine (R-BAC) in Previously Untreated Elderly Patients with Mantle Cell Lymphoma
by: Giulia Bega, et al.
Published: (2021-12-01)

Semi-Quantitative Characterization of Post-Transplant Lymphoproliferative Disorder Morphological Subtypes with [<sup>18</sup>F]FDG PET/CT
by: Filipe Montes de Jesus, et al.
Published: (2021-01-01)

Tumor Microenvironment and Immunotherapy-Based Approaches in Mantle Cell Lymphoma
by: Khalil Saleh, et al.
Published: (2022-06-01)

Spontaneous tumor lysis syndrome in hyperaggressive mantle cell lymphoma
by: Dr James Wilson
Published: (2022-08-01)

SG-APSIC1151: ZeBox: A prophylactic device against airborne infection
by: Srividya Janani Venkatraman, et al.
Published: (2023-02-01)

Immune-depleted tumor microenvironment is associated with poor outcomes and BTK inhibitor resistance in mantle cell lymphoma
by: Preetesh Jain, et al.
Published: (2023-10-01)

CAR T-cell therapy for follicular lymphoma and mantle cell lymphoma
by: Razan Mohty, et al.
Published: (2022-12-01)

P1151: BENDAMUSTINE-CONTAINING REGIMENS CAN BE SAFELY USED AS BRIDGING IN LARGE B-CELL LYMPHOMA PATIENTS RECEIVING CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY
by: Gloria Ines Iacoboni Garcia-Calvo, et al.
Published: (2023-08-01)

P1096: TREATMENT PATTERNS AND OUTCOMES IN RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA
by: A. Bock, et al.
Published: (2022-06-01)

Clay funerary figurines from tombs MMA 1151 and MMA 1152 in Sheikh Abd el-Gurna
by: Marta Kaczanowicz
Published: (2018-12-01)

Management of post-transplant lymphoproliferative disorders
by: Daan Dierickx, et al.
Published: (2019-06-01)

Tackling Mantle Cell Lymphoma in Europe
by: Denis Horgan, et al.
Published: (2022-09-01)

Primary gastric mantle cell lymphoma
by: Duska Petranovic, et al.
Published: (2012-01-01)

Educational Case: Mantle Cell Lymphoma
by: Brenda Mai MD, et al.
Published: (2020-07-01)

Diagnosis and treatment of mantle cell lymphoma
by: Felicitas Hitz, et al.
Published: (2013-11-01)

Emerging therapies in mantle cell lymphoma
by: Walter Hanel, et al.
Published: (2020-06-01)

Gastrointestinal stromal tumor with autonomic nerve differentiation and coexistent mantle cell lymphoma involving the appendix.
by: Rahimi, K, et al.
Published: (2009)

Mantle Cell Lymphoma of Mucosa-Associated Lymphoid Tissue: A European Mantle Cell Lymphoma Network Study
by: Lucia Morello, et al.
Published: (2020-02-01)

APLIKASI SISTEM PAKAR UNTUK MENDETEKSI KERUSAKAN PADA PRESSURE TRANSMITER ROSEMOUNT 1151 DENGAN METODE FUZZY
by: Masagus Mochammad Yusuf
Published: (2016-11-01)

Maintenance Treatment for Patients With Mantle Cell Lymphoma
by: Liat Vidal, et al.
Published: (2018-08-01)

Management of Drug Resistance in Mantle Cell Lymphoma
by: Gaël Roué, et al.
Published: (2020-06-01)

Atypical cytologic mantle cell lymphoma presentation
by: Mathias Chea, et al.
Published: (2022-08-01)

Chylous Ascites due to Mantle Cell Lymphoma
by: Ricardo Jorge Gonçalves Fernandes, et al.
Published: (2018-04-01)

Case report: Composite mantle cell lymphoma and classical Hodgkin lymphoma
by: Hongyu Wang, et al.
Published: (2023-03-01)

Clinical outcomes for ibrutinib in relapsed or refractory mantle cell lymphoma in real‐world experience
by: Young‐Woo Jeon, et al.
Published: (2019-11-01)

Immunochemotherapy and Maintenance With Obinutuzumab or Rituximab in Patients With Previously Untreated Marginal Zone Lymphoma in the Randomized GALLIUM Trial
by: Michael Herold, et al.
Published: (2022-03-01)

Outcome of COVID-19 in Patients With Mantle Cell Lymphoma—Report From the European MCL Registry
by: Marie-Kristin Tilch, et al.
Published: (2022-05-01)

Zanubrutinib in Mantle Cell Lymphoma Management: A Comprehensive Review
by: Alsuhebany N, et al.
Published: (2023-11-01)

Reducing and controlling metabolic active tumor volume prior to CAR T-cell infusion can improve survival outcomes in patients with large B-cell lymphoma
by: Kylie Keijzer, et al.
Published: (2024-03-01)

Mantle Cell Lymphoma Masquerading as obstructive sleep apnoea
by: Ishak, Noor Liza, et al.
Published: (2022)

Mantle cell lymphoma and involvement of lacrimal glands and orbit
by: E.V. Vilchevskaia, et al.
Published: (2016-04-01)

Mantle Cell Lymphoma Payudara, Suatu Kasus Jarang
by: Valencia Valencia, et al.
Published: (2021-02-01)

CAR T-Cell therapy for the management of mantle cell lymphoma
by: Zoufang Huang, et al.
Published: (2023-03-01)

FDG-PET in mantle cell lymphoma involving skin
by: Mehmet Sönmez, et al.
Published: (2010-12-01)

Mantle Cell Lymphoma Presenting with Acute Bilateral Ophthalmoplegia
by: Yaran Koban, et al.
Published: (2017-08-01)

FDG-PET in mantle cell lymphoma involving skin
by: Mehmet Sönmez, et al.
Published: (2010-12-01)

Temsirolimus in the treatment of relapsed and/or refractory mantle cell lymphoma
by: S Galimberti, et al.
Published: (2010-06-01)